MoonLake Immunotherapeutics
MoonLake Immunotherapeutics (MLTX) is a publicly traded company in the Unknown sector. Across all available filings, 10 corporate insiders have executed 102 transactions totaling $208.0M, demonstrating a bullish sentiment with $44.5M in net insider flow. The most recent transaction on Dec 19, 2025 involved a transaction of 196,316 shares valued at $0.
MLTX Insider Activity Summary
Who Is Buying MLTX Stock?
No significant insider buying has been recorded for MLTX in the recent period.
Who Is Selling MLTX Stock?
No significant insider selling has been recorded for MLTX in the recent period.
Is MoonLake Immunotherapeutics Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for MLTX is bullish with an Insider Alignment Score of 61/100 and a net flow of $44.5M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
MLTX Frequently Asked Questions
Understanding MLTX Insider Activity
Insider trading at MoonLake Immunotherapeutics (MLTX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 10 insiders are actively trading MLTX stock, having executed 102 transactions in the past 90 days. The most active insider is Bihua Chen (Executive), who has made 34 transactions totaling $105.8M.
Related Tools
Track MoonLake Immunotherapeutics Insider Activity
Get notified when executives and directors at MLTX file new Form 4 transactions